Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KNSA | CERT | SYRE | ||
| Company | Kiniksa Pharmaceuticals International Plc | Certara Inc | Spyre Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 21.27 | 9.58 | 27.59 | ||
| High | 21.38 | 9.80 | 29.09 | ||
| Low | 20.71 | 9.41 | 26.76 | ||
| Last | 20.90 | 9.68 | 27.49 | ||
| Change | -0.31 | +0.13 | -0.01 | ||
| % Change | -1.46% | +1.36% | -0.04% | ||
| Volume | 108,001 | 587,228 | 485,987 | ||
| 20-Day Average Volume | 358,354 | 1,057,899 | 646,385 | ||
| Previous Close | 21.21 | 9.55 | 27.50 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 22.76 | 10.35 | 33.42 | ||
| 20-Day Raw Stochastic | 10.07% | 17.35% | 10.95% | ||
| 20-Day Relative Strength | 37.06% | 37.27% | 39.50% | ||
| Weighted Alpha | +15.21 | -43.67 | +46.16 | ||
| Today's Opinion | 40% Sell | 100% Sell | 24% Sell | ||
| Previous Opinion | 24% Sell | 100% Sell | 8% Sell | ||
| Last Month's Opinion | 88% Buy | 100% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.48% since 11/14/24 | -7.41% since 11/14/24 | -12.60% since 11/14/24 | ||
| Low | 20.41 on 11/20/24 | 9.41 on 11/21/24 | 25.74 on 11/19/24 | ||
| High | 21.95 on 11/15/24 | 10.52 on 11/15/24 | 31.35 on 11/15/24 | ||
| 1-Month | |||||
| %Chg | -18.69% since 10/21/24 | -12.95% since 10/21/24 | -15.73% since 10/21/24 | ||
| Low | 20.26 on 10/29/24 | 9.41 on 11/21/24 | 25.74 on 11/19/24 | ||
| High | 28.15 on 10/28/24 | 11.44 on 10/22/24 | 40.26 on 11/12/24 | ||
| 3-Month | |||||
| %Chg | -20.36% since 08/21/24 | -24.42% since 08/21/24 | +2.86% since 08/21/24 | ||
| Low | 20.26 on 10/29/24 | 9.41 on 11/21/24 | 24.47 on 08/22/24 | ||
| High | 28.15 on 10/28/24 | 13.52 on 08/26/24 | 40.26 on 11/12/24 | ||
| 6-Month | |||||
| %Chg | +8.67% since 05/21/24 | -40.91% since 05/21/24 | -24.27% since 05/21/24 | ||
| Low | 17.38 on 07/01/24 | 9.41 on 11/21/24 | 22.19 on 06/26/24 | ||
| High | 28.15 on 10/28/24 | 17.75 on 06/05/24 | 40.26 on 11/12/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,531,404 | 1,537,311 | 1,414,352 | ||
| Shares Outstanding, K | 72,202 | 160,975 | 51,431 | ||
| Annual Sales | 270,260,000 | 354,340,000 | 890,000 | ||
| Annual Net Income | 14,080,000 | -55,360,000 | -338,790,000 | ||
| Last Quarter Sales | 112,210,000 | 94,820,000 | 0 | ||
| Last Quarter Net Income | -12,690,000 | -1,370,000 | -69,030,000 | ||
| 60-Month Beta | 0.35 | 1.51 | 2.90 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.18 on 10/29/24 | 0.13 on 11/06/24 | -1.36 on 11/07/24 | ||
| Latest Earnings Date | 10/29/24 | 11/06/24 | 11/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 44.91 | 0.00 | ||